MUFG Securities Americas’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.42M Buy
157,326
+4,152
+3% +$111K 0.28% 63
2025
Q4
$3.81M Sell
153,174
-144
-0.1% -$3.63K 0.24% 80
2025
Q3
$3.91M Buy
153,318
+27,314
+22% +$674K 0.25% 76
2025
Q2
$3.05M Buy
126,004
+25,689
+26% +$599K 0.26% 73
2025
Q1
$2.54M Buy
100,315
+16,661
+20% +$436K 0.3% 66
2024
Q4
$2.22M Buy
+83,654
New +$2.27M 0.28% 66

Other funds holding PFE

MUFG Securities Americas's PFE Position: Q1 2026 in Review

MUFG Securities Americas increased its Pfizer (PFE) stake by 2.7% in Q1 2026, buying an estimated $111K and bringing the position to 157,326 shares worth $4.42M. The position accounts for 0.28% of the portfolio, ranked #63.

MUFG Securities Americas first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • MUFG Securities Americas held 157,326 shares of Pfizer worth $4.42M as of Q1 2026.
  • MUFG Securities Americas bought 4,152 Pfizer shares in Q1 2026, an estimated $111K.
  • Pfizer made up 0.28% of MUFG Securities Americas's portfolio in Q1 2026, its #63 holding.
  • MUFG Securities Americas first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on MUFG Securities Americas's 13F filing for Q1 2026, filed 11 May 2026.